Clinical drug trials of an experimental treatment for Ebola have stopped after it was found unlikely to be effective. Health officials have been looking to abate the effects of the virus strain that has ravaged West Africa for more than a year.
Alito signs order temporarily granting relief to several Pennsylvania religious organizations, and other news
U.S. Supreme Court Justice Samuel Alito signed an order last week temporarily granting relief to several Pennsylvania religious organizations from a lower court's decision that they must notify insurers of their intention not to provide birth control to employees, or face fines under...
Texas Health Resources' debt received a rating upgrade from Moody's Investors Service, after the system demonstrated that it has recovered financially from its October Ebola crisis.
The African Centres for Disease Control and Prevention will support African ministries of health and other agencies in preventing, detecting and responding to disease outbreaks.
The Centers for Disease Control and Prevention said Tuesday that it has launched a clinical trial in Sierra Leone of the experimental Ebola vaccine that showed positive results in two previous trials.
The American Ebola patient getting treatment at the National Institutes of Health was discharged Thursday in good condition and Ebola-free, officials said.
Physicians at the National Institutes of Health updated the condition of an American healthcare worker being treated for Ebola from fair to good condition.
A hospital operator denies allegations of poor training and improper preparation in seeking dismissal of a lawsuit by a nurse who contracted while caring for the first U.S. patient to succumb to the deadly disease, a newspaper reported.
A woman in Colorado that was being evaluated for the Ebola virus has tested negative, state public health officials announced Thursday.
Texas Health Resources, the system that treated the first Ebola patient diagnosed in the U.S., reported a smaller operating margin in 2014 than the previous year as it grappled with higher expenses.
Preliminary trials of a potential vaccine against the deadly Ebola virus have shown promising signs of building immunity against the deadly disease in those who have received the treatment.
The U.S. Ebola patient being treated at the National Institutes of Health has been upgraded to serious condition from critical condition, health officials said Thursday.